Mallinckrodt to make $1.2bn acquisition

02-01-2018

Mallinckrodt to make $1.2bn acquisition

designer491 / iStockphoto.com

Mallinckrodt has revealed plans to acquire biopharmaceutical company Sucampo Pharmaceuticals for $1.2 billion.


Mallinckrodt, mergers & acquisitions, pharmaceuticals, Sucampo Pharmaceuticals, development, commercial

LSIPR